Evidence map›Paper›PMID 33340247›Full record

ArticleMolecular oncology2021

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas.

Henrik Schinke, Theresa Heider, Timm Herkommer, Florian Simon, Alexandra Blancke Soares, Gisela Kranz, Daniel Samaga, Laura Dajka, Annette Feuchtinger, Axel Walch and 13 more

Open access · goldAbstract read
In one paragraph

Article in Molecular oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Henrik SchinkeDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Theresa HeiderResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Timm HerkommerResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Florian SimonDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Alexandra Blancke SoaresDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Gisela KranzDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Daniel SamagaResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Laura DajkaResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Annette FeuchtingerResearch Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Axel WalchResearch Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Laura ValeanuInstitute of Pathology, Faculty of Medicine, LMU Munich, Germany.
Christoph WalzInstitute of Pathology, Faculty of Medicine, LMU Munich, Germany.
Thomas KirchnerInstitute of Pathology, Faculty of Medicine, LMU Munich, Germany.
Martin CanisDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Philipp BaumeisterDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.
Claus BelkaClinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum München, Neuherberg, Germany.
Cornelius MaihöferClinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum München, Neuherberg, Germany.
Sebastian MarschnerClinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum München, Neuherberg, Germany.
Ulrike PflugradtClinical Cooperation Group "Personalized Radiotherapy in Head and Neck Cancer", Helmholtz Zentrum München, Neuherberg, Germany.
Ute GanswindtDepartment of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Austria.
Julia HessResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Horst ZitzelsbergerResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Olivier GiresDepartment of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Germany.ORCID 0000-0002-2292-7064
Helmholtz Zentrum München · DELudwig-Maximilians-Universität München · DELMU Klinikum · DEInnsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous cell carcinomas (HNSCCs) have poor clinical outcome owing to therapy resistance and frequent recurrences that are among others attributable to tumor cells in partial epithelial-to-mesenchymal transition (pEMT). We compared side-by-side software-based and visual quantification of immunohistochemistry (IHC) staining of epithelial marker EpCAM and EMT regulator Slug in n = 102 primary HNSCC to assess optimal analysis protocols. IHC scores incorporated expression levels and percentages of positive cells. Digital and visual evaluation of membrane-associated EpCAM yielded correlating scorings, whereas visual evaluation of nuclear Slug resulted in significantly higher overall scores. Multivariable Cox proportional hazard analysis defined the median EpCAM expression levels resulting from visual quantification as an independent prognostic factor of overall survival. Slug expression levels resulting from digital quantification were an independent prognostic factor of recurrence-free survival, locoregional recurrence-free survival, and disease-specific survival. Hence, we propose to use visual assessment for the membrane-associated EpCAM protein, whereas nuclear protein Slug assessment was more accurate following digital measurement.

Indexed as

Epithelial-Mesenchymal TransitionAdultAgedAged, 80 and overBiomarkers, TumorEpithelial Cell Adhesion MoleculeFemaleHumansImmunohistochemistryMaleMiddle AgedPrognosisSnail Family Transcription FactorsSquamous Cell Carcinoma of Head and NeckYoung AdultBiomarkers, TumorEPCAM protein, humanEpithelial Cell Adhesion MoleculeSNAI1 protein, humanSnail Family Transcription Factorsantigen scoringEMTEpCAMHNSCCSlug

Identifiers

PMID33340247
PMCPMC8024715
OpenAlexW3116126170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.